TY - JOUR
T1 - Detection of Familial Hypercholesterolaemia: A Major Treatment Gap in Preventative Cardiology
AU - Bates, Timothy
AU - Burnett, John
AU - Van Bockxmeer, Frank
AU - Hamilton, Sandy
AU - Arnolda, Leonard
AU - Watts, Gerald
PY - 2008
Y1 - 2008
N2 - Familial hypercholesterolaemia (FH) is a common genetic disorder that untreated has an almost one hundredfold risk of coronary artery disease (CAD). In an audit of 334 patients with premature CAD admitted to a Department of Cardiology, only 60% of medical records had sufficient clinical information for identifying FH. Of those with sufficient information recorded, 54% of patients had possible to definite FH on recognised clinical criteria. Amongst those with FH, only 38%, were on statin therapy and only 22% were treated to National Heart Foundation targets. Detection and treatment of FH represents a major gap in coronary prevention.
AB - Familial hypercholesterolaemia (FH) is a common genetic disorder that untreated has an almost one hundredfold risk of coronary artery disease (CAD). In an audit of 334 patients with premature CAD admitted to a Department of Cardiology, only 60% of medical records had sufficient clinical information for identifying FH. Of those with sufficient information recorded, 54% of patients had possible to definite FH on recognised clinical criteria. Amongst those with FH, only 38%, were on statin therapy and only 22% were treated to National Heart Foundation targets. Detection and treatment of FH represents a major gap in coronary prevention.
U2 - 10.1016/j.hlc.2007.06.005
DO - 10.1016/j.hlc.2007.06.005
M3 - Article
SN - 1443-9506
VL - 17
SP - 411
EP - 413
JO - Heart, Lung and Circulation
JF - Heart, Lung and Circulation
IS - 5
ER -